有価証券レコード · アーカイブ済み四半期
GSK
GSK plc · Healthcare · Drug Manufacturers - General
18追跡対象保有者
-1Δ保有者数
242.57M保有株数
$10.47B報告済み評価額
+1新規ポジション
−3解消銘柄
モメンタム指標（同類マネージャー）：
保有者の広がり -5.3% ·
株式フロー +2.4% ·
新規ネットポジション数 -11.1%
— 計算式
集中的な買い集め — 保有者数が減少する中で株式数が増加
すべての保有状況データ：追跡対象13Fマネージャーのみ、普通株ポジション、報告期間 Q3 2025
保有状況の推移
| 四半期 | 保有者 | Δ | 株数 | 報告済み評価額 | 新規 | 解消銘柄 |
|---|---|---|---|---|---|---|
| Q2 2026 | 118 | +2 | 291.90M | $15.17B | +8 | −5 |
| Q1 2026 | 116 | 0 | 315.42M | $17.28B | +8 | −8 |
| Q4 2025 | 115 | +4 | 328.16M | $15.98B | +4 | — |
| Q3 2025 | 18 | -1 | 242.57M | $10.47B | +1 | −3 |
| Q2 2025 | 17 | +1 | 220.73M | $8.48B | +2 | −1 |
| Q1 2025 | 14 | -1 | 157.56M | $6.11B | — | −1 |
| Q4 2024 | 15 | -1 | 135.53M | $4.59B | — | −1 |
| Q3 2024 | 15 | +3 | 120.78M | $4.99B | +3 | — |
| Q2 2024 | 12 | — | 118.47M | $4.56B | — | — |
保有者情報 · Q3 2025
| # | 運用会社 | 株数 | Δ株式数 | 時価 | そのウェイト | 保有中 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Dodge & Cox ✦ | 78.40M | -0.5% | $3.38B | 1.8% | ▼ Trim | 6 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 66.14M | +8.4% | $2.85B | 0.1% | ▲ Add | 2 | SEC ↗ |
| 3 | Fidelity (FMR) ✦ | 66.14M | +8.4% | $2.85B | 0.1% | ▲ Add | 2 | SEC ↗ |
| 4 | Fidelity (FMR) ✦ | 66.14M | +8.4% | $2.85B | 0.1% | ▲ Add | 2 | SEC ↗ |
| 5 | Fidelity (FMR) ✦ | 66.14M | +8.4% | $2.85B | 0.1% | ▲ Add | 2 | SEC ↗ |
| 6 | Fisher Asset Management ✦ | 32.23M | +2.8% | $1.39B | 0.5% | ▲ Add | 6 | SEC ↗ |
| 7 | PRIMECAP Management ✦ | 25.77M | -7.1% | $1.11B | 0.9% | ▼ Trim | 6 | SEC ↗ |
| 8 | T. Rowe Price ✦ | 7.95M | -1.2% | $343.21M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 9 | T. Rowe Price ✦ | 7.95M | -1.2% | $343.21M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 10 | State Street Global Advisors ✦ (パッシブ) | 6.62M | -1.4% | $288.71M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 11 | Goldman Sachs Group ✦ | 6.52M | — | $281.36M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Goldman Sachs Group ✦ | 6.52M | — | $281.36M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Goldman Sachs Group ✦ | 6.52M | — | $281.36M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Goldman Sachs Group ✦ | 6.52M | — | $281.36M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Morgan Stanley ✦ | 4.95M | — | $213.61M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Morgan Stanley ✦ | 4.95M | — | $213.61M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Morgan Stanley ✦ | 4.95M | — | $213.61M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Morgan Stanley ✦ | 4.95M | — | $213.61M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Morgan Stanley ✦ | 4.95M | — | $213.61M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Morgan Stanley ✦ | 4.95M | — | $213.61M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Morgan Stanley ✦ | 4.95M | — | $213.61M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Morgan Stanley ✦ | 4.95M | — | $213.61M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Morgan Stanley ✦ | 4.95M | — | $213.61M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | JPMorgan Chase ✦ | 4.70M | — | $202.85M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | JPMorgan Chase ✦ | 4.70M | — | $202.85M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | JPMorgan Chase ✦ | 4.70M | — | $202.85M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | JPMorgan Chase ✦ | 4.70M | — | $202.85M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | JPMorgan Chase ✦ | 4.70M | — | $202.85M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | JPMorgan Chase ✦ | 4.70M | — | $202.85M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | JPMorgan Chase ✦ | 4.70M | — | $202.85M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | JPMorgan Chase ✦ | 4.70M | — | $202.85M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | JPMorgan Chase ✦ | 4.70M | — | $202.85M | 0.0% | n/c | 1 | SEC ↗ |
| 33 | JPMorgan Chase ✦ | 4.70M | — | $202.85M | 0.0% | n/c | 1 | SEC ↗ |
| 34 | JPMorgan Chase ✦ | 4.70M | — | $202.85M | 0.0% | n/c | 1 | SEC ↗ |
| 35 | JPMorgan Chase ✦ | 4.70M | — | $202.85M | 0.0% | n/c | 1 | SEC ↗ |
| 36 | JPMorgan Chase ✦ | 4.70M | — | $202.85M | 0.0% | n/c | 1 | SEC ↗ |
| 37 | JPMorgan Chase ✦ | 4.70M | — | $202.85M | 0.0% | n/c | 1 | SEC ↗ |
| 38 | JPMorgan Chase ✦ | 4.70M | — | $202.85M | 0.0% | n/c | 1 | SEC ↗ |
| 39 | JPMorgan Chase ✦ | 4.70M | — | $202.85M | 0.0% | n/c | 1 | SEC ↗ |
| 40 | JPMorgan Chase ✦ | 4.70M | — | $202.85M | 0.0% | n/c | 1 | SEC ↗ |
| 41 | JPMorgan Chase ✦ | 4.70M | — | $202.85M | 0.0% | n/c | 1 | SEC ↗ |
| 42 | JPMorgan Chase ✦ | 4.70M | — | $202.85M | 0.0% | n/c | 1 | SEC ↗ |
| 43 | JPMorgan Chase ✦ | 4.70M | — | $202.85M | 0.0% | n/c | 1 | SEC ↗ |
| 44 | Wellington Management ✦ | 3.42M | +135.1% | $147.62M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 45 | Wellington Management ✦ | 3.42M | +135.1% | $147.62M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 46 | Wellington Management ✦ | 3.42M | +135.1% | $147.62M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 47 | Wellington Management ✦ | 3.42M | +135.1% | $147.62M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 48 | Wellington Management ✦ | 3.42M | +135.1% | $147.62M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 49 | Renaissance Technologies ✦ | 1.99M | -11.7% | $85.80M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 50 | BlackRock ✦ (パッシブ) | 1.97M | +23.1% | $85.21M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 51 | BlackRock ✦ (パッシブ) | 1.97M | +23.1% | $85.21M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 52 | Bridgewater Associates ✦ | 1.40M | +4.3% | $60.50M | 0.2% | ▲ Add | 6 | SEC ↗ |
| 53 | AQR Capital Management ✦ | 203.61K | +282.1% | $8.79M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 54 | AQR Capital Management ✦ | 203.61K | +282.1% | $8.79M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 55 | AQR Capital Management ✦ | 203.61K | +282.1% | $8.79M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 56 | AQR Capital Management ✦ | 203.61K | +282.1% | $8.79M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 57 | Two Sigma Investments ✦ | 89.50K | 0.0% | $3.86M | 0.0% | Held | 5 | SEC ↗ |
| 58 | Tweedy, Browne ✦ | 82.24K | -5.3% | $3.55M | 0.3% | ▼ Trim | 6 | SEC ↗ |
| 59 | Millennium Management ✦ | 64.99K | -17.1% | $2.80M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 60 | Marshall Wace ✦ | 63.89K | 新規 | $2.76M | 0.0% | New | 1 | SEC ↗ |
「当該ウェイト」= そのマネージャーの報告済み13F株式評価額に占めるポジションの割合（確信度の指標）。✦ = キュレーション済みマネージャー。
新規買い手
| Marshall Wace | $2.76M | 0.0% |
ポジション解消済み
| Citadel Advisors | $4.67M | だった 0.0% |
| Norges Bank | $2.11M | だった 0.0% |
| Adage Capital Partners | $344,333 | だった 0.0% |
市場全体のコンテキスト: 全13Fファイラー対象（SEC構造化データ、 Q1 2026): 2 保有者, 16.10M 株式数, $459.30M 報告済み. これは上記の追跡対象ユニバースの数値とは異なる、より古い期間のものであり、両者が混在することはありません。
共同保有が多い銘柄
この有価証券の追跡対象保有者が最も頻繁に保有する他の銘柄 — ファンダメンタルな関係ではなく、共同保有件数に基づきます。